awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q27014080-79D39B3E-77E3-44BE-AE2E-EF722D9D8D13
Q27014080-79D39B3E-77E3-44BE-AE2E-EF722D9D8D13
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27014080-79D39B3E-77E3-44BE-AE2E-EF722D9D8D13
Molecular pathways: targeting the dependence of mutant RAS cancers on the DNA damage response
P2860
Q27014080-79D39B3E-77E3-44BE-AE2E-EF722D9D8D13
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27014080-79D39B3E-77E3-44BE-AE2E-EF722D9D8D13
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
662d01c8bb9e83619430480c5cb5a9c1c6c7297f
P2860
Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer.